| Clinical Outcomes on ErbB2+ MBC Patients Treated With Lapatinib-Capecitabine After Trastuzumab Progression: Role of Early Versus Late Switch to Lapatinib-Capecitabine (TYCO) |
Ongoing |
Lapatinib / Capecitabine |
4 |
113780 |
King Abdulaziz Medical City NG (Riyadh) , King Faisal Specialist Hospital and Research Center (Riyadh), King Abdulaziz Hospital and Oncology Center (Jeddah) |
| Prevalence of Cardiovascular Risk Factors in Patients Attending General Practice Clinics in Selected Countries in the Africa and The Middle East : AFME Cardiovascular Epidemiology (ACE) Study. |
Ongoing |
N/A |
4 |
A2581186 |
Dallah Hospital (Riyadh), Al Mana General Hospital (Khobar), University District Hospital (Jeddah), Al Shifa Medical Hospital (Makkah) |
| Changing Diabetes® World Tour |
Ongoing |
N/A |
4 |
version 6 - October 2010 |
King Abdulaziz University Hospital (Jeddah) |
| An observational study to evaluate caregiver's preference and treatment outcome in patient with alzheimer's disease treated with oral or tramsdermal monotheraby - Real-World Evaluation of compliance and preference in the treatment of Alzheimer's disease(RECAP). |
Ongoing |
Rivastigmine |
4 |
CENA713D-MAX-SA-01 |
Dr. Soliman Fakeeh Hospital (Jeddah) |
| DISCOVER Study - Drug Treatment Reality of Type 2 Diabetes in Real World Settings Internationally -D1690R00002 |
Ongoing |
N/A |
4 |
D1690R0000 |
King Fahad Medical City (Riyadh), Aseer Central Hospital, King Salman Bin AbdulAziz Hospital (Riyadh), Prince Mutaib Bin Abdul Aziz Hospital (Sakaka), King Khalid University Hospital (Riyadh), Armed Forces Hospital (khamis mushait), King Abdulaziz Hospital and Oncology Center (Jeddah), King Fahad Hospital (Jeddah) |
| A Prospective Observational Study on the home treatment of haemarthrosis with VIIa (activated recombinant factor VII) in haemophilia A and B patient with inhibitors |
Ongoing |
NovoSeven (activated recombinant factor VII) |
4 |
F7HEAM-3850 |
King Khalid University Hospital (Riyadh) |
| A multicenter, observational, phase IV study of the use of Pregabalin (Nervax®) on adult patients for the management of Neuropathic pain in Saudi Arabia |
Ongoing |
NERVAX |
4 |
N-001 |
King Fahad Medical City (Riyadh) |
| Saudi rEgistry of Cardiovascular Risk factor managEmenT in HemoDialysis patients |
Ongoing |
N/A |
4 |
2 |
King Abdulaziz University Hospital (Jeddah), King Fahad Hospital (Jeddah), King Khalid General Hospital (Hail), King Abdulaziz University Hospital (Jeddah), Al-Noor Specialist Hospital (Makkah), Dr. Soliman Fakeeh Hospital (Jeddah), King Salman Kidney Diseases Center (Riyadh) |
| Multinational, Prospective, Observational Study to Assess the Unmet Medical Needs associated with Basal Insulin Use in Patients with Type 2 Diabetes Newly or Recently Initiated with Basal Insulin Treatment |
Ongoing |
N/A |
4 |
OBS13780 |
King Khalid University Hospital (Riyadh) |
| A multicenter, observational, prospective study of the use of Diclofenac Sodium 75 mg Dual Release Capsules (Divido®) on adult patients with persistent or chronic pain and inflammation in Saudi Arabia |
Ongoing |
Divido |
4 |
D-001 |
King Fahad Medical City (Riyadh) |
